Related Experiment Video
Updated: Apr 21, 2026
08:58
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
9.3K
[Diagnostic and therapeutic update in narcolepsy].
1Servicio de Neurología, Unidad Multidisciplinar de Trastornos del Sueño, Hospital Clinic de Barcelona, Villaroel 170, Barcelona, Spain. jsantama@clinic.ub.es
Revista De Neurologia
|May 19, 2012
Summary
Narcolepsy, a sleep disorder, involves excessive sleepiness and cataplexy due to hypocretin neuron loss. While a cure is unavailable, current treatments significantly improve symptoms for many patients.
Area of Science:
- Neurology
- Immunology
- Sleep Medicine
Background:
- Narcolepsy is a distinct sleep disorder characterized by excessive daytime sleepiness and cataplexy.
- Recent advances have identified the loss of hypocretin-producing neurons as a key feature.
- An autoimmune process, linked to specific HLA and T-cell receptor types, is implicated in its pathogenesis.
Purpose of the Study:
- To summarize the current understanding of narcolepsy's causes and mechanisms.
- To review available treatments for narcolepsy symptoms.
- To highlight the impact of diagnostic delays, especially in pediatric cases.
Main Methods:
- Review of recent scientific literature on narcolepsy.
- Analysis of etiological and pathogenetic findings.
- Evaluation of current therapeutic strategies.
Main Results:
- Narcolepsy is linked to the loss of hypothalamic neurons synthesizing hypocretin.
- An autoimmune mechanism involving specific genetic markers is suggested.
- Effective symptomatic treatments exist, though a definitive cure is lacking.
Conclusions:
- Significant progress has been made in understanding narcolepsy's neurobiological basis.
- Symptomatic treatments offer substantial relief for patients.
- Increased awareness is crucial to reduce diagnostic delays and improve patient outcomes.
More Related Videos
Related Concept Videos
01:24Sleep-Wake Cycles
2.9K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.9K
01:23Sedatives and Hypnotics: Overview
2.2K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.2K
01:19Management of Insomnia
761
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
761
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
942
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
942
01:16Therapeutic Drug Monitoring: Overview and Classification
614
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
614
01:07Narcolepsy
872
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
872